Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
about
Trace elements in hemodialysis patients: a systematic review and meta-analysisPivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stressPositive relationship between total antioxidant status and chemokines observed in adults.Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.Uremia alters HDL composition and functionCyanate is a novel inducer of endothelial icam-1 expression.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease.C-reactive protein in end-stage renal disease: are there reasons to measure it?Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.Kidneys, hearts, hormones and immunomodulators: integrated understandings.Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injuryInflammation regulates fibroblast growth factor 23 production.Pathophysiological and clinical aspects of malnutrition in chronic renal failure.Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysisMineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study.Smoking cessation pharmacotherapy.Renal vascular structure and rarefaction.Ironing out the cross talk between FGF23 and inflammation.Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes.The urea decomposition product cyanate promotes endothelial dysfunction.Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics.Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients.Telomere Length in Peripheral Blood Mononuclear Cells of Patients on Chronic Hemodialysis Is Related With Telomerase Activity and Treatment Duration.
P2860
Q28389374-0A5790FA-D9D8-4936-9517-FFC1DFB142A8Q33727573-F4C12A18-5981-4246-B75D-069C35AF5686Q34185032-ECD0BA3A-96C7-4A10-9D44-6610EF69BC4BQ34613937-3C5C48BF-4021-43BC-AB30-4C9CBC45AA86Q35210194-410588E6-9ADA-4A8E-9B3C-D9C373BD9C55Q35567375-3C2D1EB7-89DC-49A7-B8F1-8B441FBE9D21Q35818228-2C5DAFEB-23B4-4588-910D-4E296EBB9555Q35879090-33BD7267-4D89-4659-AD17-2E7D96CC5C0CQ35997686-5FE13455-EB03-4E67-A6E7-B82C71B49419Q36069621-94F9ECF1-EBC9-43FB-8182-83B9FA9C8186Q36345535-480A5B56-B9D5-4139-A478-65E39B088CECQ36760107-5EBC5D44-47DA-44E1-8E14-68468866E849Q36956739-F228AFDF-2130-4D13-A559-A16C578E7562Q37243107-0E08424C-AEA3-4214-B461-9E93992E3CBEQ37350040-B655A7EF-F5F7-4804-8257-F0CAAB7C7B25Q37367707-1BB47019-6A22-47E8-A0FF-57E31D4C7B13Q37378445-9CDB2F0E-294D-4DB8-A80C-004A3E530DFDQ37505737-7FC70C5E-FA60-42DA-A8A5-ABA56AF85B73Q37605855-EA53EDCB-A08E-4050-95EC-278C8313FC59Q38942965-42450B87-7B90-4B7E-8CEC-832E2DE1C569Q38961965-C925642D-5E59-437A-9D0A-6995674A3858Q42025075-D4EF0FE4-3F1B-4AEB-8C4A-3FE3B527DE89Q43063347-F1E2EEE4-B353-494E-8561-974F2E3B8AB8Q46534745-170D8306-D206-436B-9EF5-064D893D3FEAQ50561980-635B76D5-318F-4F7B-BC78-CE6C1265FDDB
P2860
Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interactions between inflammat ...... on in end-stage renal disease.
@ast
Interactions between inflammat ...... on in end-stage renal disease.
@en
type
label
Interactions between inflammat ...... on in end-stage renal disease.
@ast
Interactions between inflammat ...... on in end-stage renal disease.
@en
prefLabel
Interactions between inflammat ...... on in end-stage renal disease.
@ast
Interactions between inflammat ...... on in end-stage renal disease.
@en
P356
P1476
Interactions between inflammat ...... on in end-stage renal disease.
@en
P2093
Peter Stenvinkel
P304
P356
10.1053/JREN.2003.50018
P577
2003-04-01T00:00:00Z